John Tsai insider trades
Open-market stock purchases and sales by John Tsai, Director at Blueprint Medicines Corp, from SEC Form 4 filings since Jan 6, 2023.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- BPMC Blueprint Medicines Corp: other filings, last Jul 17, 2025